Serge Alexanian
Anatomic Pathology & Clinical Pathology · Los Angeles, CANPI 1437537412
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,887,877 of the $3,156,944 with a category attached, or 91.5%. 13 manufacturers reported payments, led by Agilent Technologies, Inc. at 37.4% of the total. 2025 is the largest year on record at $775,282, 4.8 times the $163,008 reported in 2019. Among anatomic pathology & clinical pathology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 429 payments — averaging $7358.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Agilent Technologies, Inc.$1.2M
- Incyte Corporation$890K
- Stemline Therapeutics Inc.$749K
- X4 Pharmaceuticals, Inc.$180K
- Syndax Pharmaceuticals, Inc.$102K
- Leica Microsystems Inc.$14K
- plus $42K from 7 others
What the payments were for
- Consulting fees$2,887,87791%
- Speaking & faculty fees$236,5247%
- Travel & lodging$26,8831%
- Food & beverage$5,6600%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Agilent Technologies, Inc. | 18 | $1,179,673 |
| Incyte Corporation | 83 | $889,610 |
| Stemline Therapeutics Inc. | 246 | $749,467 |
| X4 Pharmaceuticals, Inc. | 7 | $180,000 |
| Syndax Pharmaceuticals, Inc. | 41 | $102,011 |
| Leica Microsystems Inc. | 3 | $14,362 |
| E.r. Squibb & Sons, L.L.C. | 11 | $10,939 |
| Merck Healthcare Kgaa | 1 | $10,625 |
| AbbVie | 9 | $8,279 |
| Merck Kgaa | 1 | $4,375 |
| Roche Diagnostics Corporation | 3 | $4,157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $3,163 |
| Blueprint Medicines Corporation | 4 | $284 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PD-L1 IHC 22C3$599,075
- PD-L1 IHC 22C3 pharmDx$469,915
- ELZONRIS$229,236
- XOLREMDI$180,000
- Omnis$71,873
- PD-L1 IHC 28-8 pharmDx$28,840
- OPDIVO$8,905
- Elahere$7,425
- BOND-III processing module$7,325
- VIRTUOSO System for IHC$4,000
- Reblozyl$1,800
- AYVAKIT$121
- REVUFORJ$117
- iScan Coreo$101
How this compares
$3,156,944 in reported general payments places this provider in the 95th percentile of 814 anatomic pathology & clinical pathology providers in California.
See all anatomic pathology & clinical pathology providers in California →
Other anatomic pathology & clinical pathology in Los Angeles
- Brian ConeLos Angeles$519K
- Michael LewisLos Angeles$220K
- Mark HaasLos Angeles$175K
- Fausto RodriguezLos Angeles$87K
- Scott NelsonLos Angeles$81K
- Nam KuLos Angeles$80K
- Jess SavalaLos Angeles$62K
- Elias MakhoulLos Angeles$41K
- Maria del Carmen Frias KleteckaLos Angeles$29K
- Jonathan BraunLos Angeles$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.